CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Corporate Subsidiaries
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) is a publicly traded company on the NYSE, categorized under SIC 8731 (Services-Commercial Physical & Biological Research). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CRL
CIK: 1100682
Exchange: NYSE
SIC 8731: Services-Commercial Physical & Biological Research
Fiscal Year End: 12/27
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJeffrey Hemman
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001952784-26-000003 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001969223-26-001063 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0001100682-26-000144 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-24 | 8-K | 0001100682-26-000142 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-08 | — | SCHEDULE 13G/A Filing | 0000315066-26-002294 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-25 | PRIMARY DOCUMENT | 0001100682-26-000140 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001969223-26-000955 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-19 | PRIMARY DOCUMENT | 0001100682-26-000138 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-19 | PRIMARY DOCUMENT | 0001100682-26-000136 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | PRIMARY DOCUMENT | 0001100682-26-000134 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001969223-26-000932 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001969223-26-000918 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | PRIMARY DOCUMENT | 0001100682-26-000132 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | PRIMARY DOCUMENT | 0001100682-26-000130 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0000914208-26-000275 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | PRIMARY DOCUMENT | 0001100682-26-000128 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | PRIMARY DOCUMENT | 0001100682-26-000126 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001969223-26-000886 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001969223-26-000885 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | PRIMARY DOCUMENT | 0001100682-26-000124 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | PRIMARY DOCUMENT | 0001100682-26-000122 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001969223-26-000874 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-05 | PRIMARY DOCUMENT | 0001100682-26-000120 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001969223-26-000853 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001969223-26-000852 | View SEC Doc Filr Page |